(Reuters) - U.S. drugstore chain Walgreens Boots Alliance ( WBA ) said on Thursday it has sold more shares in drug distributor Cencora ( COR ) for proceeds of about $300 million.

The company said that it now owns a 6% stake in Cencora ( COR ), trimming it down from 10% it previously held. It sold Cencora ( COR ) shares worth $1.1 billion in August.

Walgreens has sold about $265 million worth of shares and Cencora ( COR ) has agreed to repurchase about $50 million worth of shares, the company said in a statement.

Proceeds from the share sale will be used primarily for debt pay down and general corporate purposes, as Walgreens continues to build out a more capital-efficient health services strategy rooted in its retail pharmacy footprint.

The pharmacy chain reiterated that the sale has no impact to the long-term partnership between the two companies.